These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1289616)

  • 1. Recombinant human epidermal growth factor and corneal neovascularization.
    Nezu E; Ohashi Y; Kinoshita S; Manabe R
    Jpn J Ophthalmol; 1992; 36(4):401-6. PubMed ID: 1289616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of recombinant epidermal growth factor in corneal angiogenesis].
    Taniguchi E; Nagae Y; Watanabe H; Ohashi Y; Kinoshita S; Manabe R
    Nippon Ganka Gakkai Zasshi; 1991 Jan; 95(1):52-8. PubMed ID: 1710416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
    Knighton DR; Phillips GD; Fiegel VD
    J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained-release endotoxin. A model for inducing corneal neovascularization.
    Li WW; Grayson G; Folkman J; D'Amore PA
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2906-11. PubMed ID: 1917394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of rabbit corneal alkali wounds with human epidermal growth factor.
    Chung JH; Fagerholm P
    Cornea; 1989; 8(2):122-8. PubMed ID: 2469551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug modification of angiogenesis in a rat cornea model.
    Schwartz S; George J; Ben-Shoshan J; Luboshits G; Avni I; Levkovitch-Verbin H; Ziv H; Rosner M; Barak A
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):250-4. PubMed ID: 18172099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model of angiogenesis in the mouse cornea.
    Kenyon BM; Voest EE; Chen CC; Flynn E; Folkman J; D'Amato RJ
    Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1625-32. PubMed ID: 8675406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide.
    BenEzra D; Griffin BW; Maftzir G; Aharonov O
    Invest Ophthalmol Vis Sci; 1993 Dec; 34(13):3601-8. PubMed ID: 8258518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
    Ma X; Ottino P; Bazan HE; Bazan NG
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Shan S; Lockhart AC; Saito WY; Knapp AM; Laderoute KR; Dewhirst MW
    Clin Cancer Res; 2001 Aug; 7(8):2590-6. PubMed ID: 11489843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental corneal neovascularization by basic fibroblast growth factor incorporated into gelatin hydrogel.
    Yang CF; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Tabata Y; Ikada Y; Ogura Y
    Ophthalmic Res; 2000; 32(1):19-24. PubMed ID: 10657751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis effects of nerve growth factor (NGF) on rat corneas.
    Seo K; Choi J; Park M; Rhee C
    J Vet Sci; 2001 Aug; 2(2):125-30. PubMed ID: 14614283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor.
    Loughman MS; Chatzistefanou K; Gonzalez EM; Flynn E; Adamis AP; Shing Y; D'Amato RJ; Folkman J
    Aust N Z J Ophthalmol; 1996 Aug; 24(3):289-95. PubMed ID: 8913136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of experimental angiogenesis of cornea by somatostatin.
    Wu PC; Liu CC; Chen CH; Kou HK; Shen SC; Lu CY; Chou WY; Sung MT; Yang LC
    Graefes Arch Clin Exp Ophthalmol; 2003 Jan; 241(1):63-9. PubMed ID: 12545294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model.
    Gaudric A; N'guyen T; Moenner M; Glacet-Bernard A; Barritault D
    Ophthalmic Res; 1992; 24(3):181-8. PubMed ID: 1407961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human recombinant epidermal growth factor in experimental corneal wound healing.
    Brazzell RK; Stern ME; Aquavella JV; Beuerman RW; Baird L
    Invest Ophthalmol Vis Sci; 1991 Feb; 32(2):336-40. PubMed ID: 1993585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism of accelerated corneal epithelial healing by human epidermal growth factor.
    Kitazawa T; Kinoshita S; Fujita K; Araki K; Watanabe H; Ohashi Y; Manabe R
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1773-8. PubMed ID: 2211024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of cysteine proteases in bFGF-induced angiogenesis in guinea pig and rat cornea.
    Tamada Y; Fukiage C; Boyle DL; Azuma M; Shearer TR
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):271-83. PubMed ID: 10872924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role of transforming growth factor-beta 1 in the control of corneal neovascularization.
    Friling R; Yassur Y; Levy R; Kost J; Schwartz B; Mikhailowsky R; Lamprecht SA
    In Vivo; 1996; 10(1):59-64. PubMed ID: 8726812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.